JP Morgan Chase
IBIO icon

JP Morgan Chase’s iBio IBIO Stock Holding History

JP Morgan Chase’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2K Buy
5,897
+5,895
+294,750% +$10.5K ﹤0.01% 6912
2026
Q1 		$3 Hold
2
– – ﹤0.01% 7466
2025
Q4 		$4 Hold
2
– – ﹤0.01% 7362
2025
Q3 		$2 Hold
2
– – ﹤0.01% 7347
2025
Q2 		$2 Hold
2
– – ﹤0.01% 7012
2025
Q1 		$8 Hold
2
– – ﹤0.01% 7199
2024
Q4 		$5 Hold
2
– – ﹤0.01% 7336
2024
Q3 		$4 Hold
2
– – ﹤0.01% 7334
2024
Q2 		$4 Hold
2
– – ﹤0.01% 7252
2024
Q1 		$8 Hold
2
– – ﹤0.01% 7250
2023
Q4 		$3 Sell
2
-1
-33% -$4 ﹤0.01% 7461
2023
Q3 		$15 Hold
3
– – ﹤0.01% 7228
2023
Q2 		$31 Hold
3
– – ﹤0.01% 6768
2023
Q1 		$0 Hold
3
– – ﹤0.01% 6950
2022
Q4 		$0 Hold
3
– – ﹤0.01% 6755
2022
Q3 		$0 Hold
3
– – ﹤0.01% 6633
2022
Q2 		$0 Sell
3
-202
-99% -$30.4K ﹤0.01% 6654
2022
Q1 		$44K Buy
205
+37
+22% +$7.74K ﹤0.01% 5845
2021
Q4 		$46K Hold
168
– – ﹤0.01% 5983
2021
Q3 		$90K Sell
168
-204
-55% -$127K ﹤0.01% 5624
2021
Q2 		$280K Sell
372
-809
-69% -$590K ﹤0.01% 5062
2021
Q1 		$909K Buy
1,181
+185
+19% +$161K ﹤0.01% 4300
2020
Q4 		$523K Buy
996
+749
+303% +$610K ﹤0.01% 4341
2020
Q3 		$258K Buy
247
+167
+209% +$242K ﹤0.01% 4249
2020
Q2 		$88K Buy
+80
New +$52.3K ﹤0.01% 4620

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

JP Morgan Chase's IBIO Position: Q2 2026 in Review

JP Morgan Chase increased its iBio (IBIO) stake by 294,750% in Q2 2026, buying an estimated $10.5K and bringing the position to 5,897 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6912.

JP Morgan Chase first reported a position in IBIO in Q2 2020 and has held it in 25 quarters since. The position peaked at $909K in Q1 2021. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • JP Morgan Chase held 5,897 shares of iBio worth $10.2K as of Q2 2026.
  • JP Morgan Chase bought 5,895 iBio shares in Q2 2026, an estimated $10.5K.
  • iBio made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6912 holding.
  • JP Morgan Chase first reported a position in iBio in Q2 2020 and has held it in 25 quarters since.
  • JP Morgan Chase's iBio position peaked at $909K in Q1 2021.
  • 55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.